Basel, Switzerland, 12.01.2021 – BVL-GSK098 IS BEING DEVELOPED FOR THE TREATMENT OF MULTI-DRUG RESISTANT TUBERCULOSIS INFECTIONS
30.07.2020 – Improving the success of R&D efforts in the fight against AMR is one of the long-term goals of COMBINE. To this end, the consortium calls upon the AMR community to share data from studies of prevention or treatment of bacterial infections.
Basel, 23.06.2020 – BVL-GSK098 IS BEING DEVELOPED FOR THE TREATMENT OF MULTI-DRUG RESISTANT TUBERCULOSIS INFECTIONS
Utrecht, 24.06.2020 – Despite the restrictions of Covid-19, the GNA NOW Consortium enjoyed a successful first annual meeting on Wednesday 24 June. Held online, the half-day meeting brought together 29 Consortium members to discuss the results achieved to date and the plans for the upcoming year.